Corline Biomedical AB (OM: CLBIO)
Health Care · Pharmaceuticals · SE
Skr13.70
0.00% today · -30.8% 1Y
Corline Biomedical AB (OM: CLBIO) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $35.81M and employs 14 people.
Over the last twelve months the share price has lost 30.8%, trading between 13.15 and 22.30.
Tweenvest scores Corline Biomedical AB across four factors: quality 54/100, value 54/100, growth 0/100. Its strongest factor is quality.
CLBIO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $35.81M
- Revenue (TTM)
- $1.28M
- P/E
- —
- EPS
- -0.48
- Dividend yield
- —
- Beta (5Y)
- 0.34
- 52-week high
- Skr22.30
- 52-week low
- Skr13.15
- Avg volume (3M)
- —
- Shares outstanding
- 26.13M
- Employees
- 14
- Next earnings
- —
About Corline Biomedical AB
Corline Biomedical AB is a company dedicated to the creation, production, and distribution of heparin-based solutions. These solutions are specifically engineered to enhance outcomes in kidney transplantation, cellular therapies, and regenerative medicine. At the heart of their product line is the proprietary Corline Heparin Conjugate (CHC) technology, a unique heparin conjugate that can function as a standalone pharmaceutical compound. The company's diverse portfolio includes Renaparin, aimed at treating end-stage renal failure; Cytoparin, a cell therapy designed for patients with type 1 diabetes; the CHC compound itself for addressing soft tissue injuries; and a variety of medical devices, such as CHS, a coronary stent. Established in 1991, Corline Biomedical AB operates from its headquarters in Uppsala, Sweden.
- ISIN
- SE0006887451
- Founded
- 1991
- Listed since
- Jun 3, 2015
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| China Pharma Holdings, Inc.NYSEAM: CPHI | $37.45M | $0.83 | -4.86% |
| Impact BioMedical Inc.NYSEAM: IBO | $36.31M | $4.03 | -5.18% |
| Rhone Ma Holdings BerhadKLSE: RHONEMA | $36.29M | RM0.67 | -0.74% |
| Anxo Pharmaceutical Co., Ltd.TPEX: 6677 | $35.93M | NT$20.50 | +7.89% |
| Nippon Chemiphar Co., Ltd.TSE: 4539 | $35.79M | ¥1,564.00 | -0.57% |
| Beit Jala Pharmaceutical CompanyPLSE: BJP | $35.75M | JD— | — |
| Biomind Labs Inc.OTCPK: BMND.F | $35.68M | $— | — |
| Astonea Labs LimitedBSE: 544409 | $35.19M | Rs324.00 | -6.09% |
Figures last refreshed Oct 11, 2026.